Migraine is more than just a headache-it can involve changes in the brain and inflammation. Recent research suggests that acupuncture may help by calming pain signals and reducing inflammation in the body. Scientists are studying whether acupuncture can also lower certain markers in the blood that show brain stress or inflammation. While more research is needed, acupuncture is considered safe and may reduce the number and severity of migraine attacks for many people. Acupuncture has been used for over 40 years in our practice to manage acute and chronic pain, including migraines. When performed by trained physicians, it is safe and typically reduces headache frequency and intensity, as well as nausea and vomiting, lowering the need for pain medication. Investigators are exploring three different ways to help manage migraine headaches using gentle stimulation techniques. These include laser acupuncture, electroacupuncture, and traditional acupuncture. Investigators want to see which method works best for reducing migraine symptoms. Investigators will look at how participants feel after treatment and also check blood samples for signs of inflammation and certain substances linked to migraines, such as calcitonin gene-related peptide (CGRP) and markers of brain stress. Investigators have a goal to find safe and effective options that can improve migraine care and help people feel better.
Investigators are conducting a study to compare three different types of acupuncture treatments. Each participant will be carefully evaluated to meet the requirements for participation. Before joining, each participant will have a conversation with investigators to explain the study and answer any questions. Participants will be randomly placed into one of three groups: Traditional Acupuncture - standard acupuncture treatment Electroacupuncture - standard acupuncture combined with gentle electrical stimulation. Laser Acupuncture - standard acupuncture combined with acupuncture using a low-level laser instead of needles. After the treatment, Investigators will check in with participants again after 1 and 3 months to see how they are feeling and whether the effects have lasted.Participation is voluntary, with no financial compensation, and care will not be affected by the decision to participate. Outcomes will be assessed using questionnaires before treatment and for three months afterward, measuring migraine days, pain intensity, medication use, headache frequency, and satisfaction of participants. Blood samples will be collected at baseline, after treatment, and three months later to analyze migraine-related biomarkers. Results will be statistically evaluated. Investigators expect acupuncture to reduce headache severity and medication use. So far, there has been no direct comparison of these three methods. Investigators want to find out: Which method works best. How long the benefits last. Whether participants need repeat treatments.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
75
standard acupuncture on the scalp and distal acupuncture point that will not be stimulated with electro or laser device
Electroacupuncture - distal acupuncture points will be stimulated will electronic device that is used for electroacupuncture
Distal acupuncture points will be stimulated with laser needles
Clinical department of anaesthesiology and surgical intensive therapy University Medical Centre Ljubljana
Ljubljana, Slovenia
NRS 3
Pain intensity three months after treatment measured with NRS (Numeric rate scale) from 0 (for = pain) to 10 (maximal pain)
Time frame: Baseline and three months from last acupuncture stimulation
HIT- 6
HIT-6 stands for Headache Impact Test - 6 items.Higher scores indicate a greater impact of migraine on the life of partcipants. The four headache impact severity categories are little or no impact (49 or less), some impact (50-55), substantial impact (56-59), and severe impact (60-78) Score range 36-78 It is widely used for people with migraine or other headache disorders. The goal is to understand the impact of headaches on daily functioning, not just pain intensity.
Time frame: Baseline and three months from last acupuncture stimulation
MIDAS
The MIDAS questionnaire stands for Migraine Disability Assessment. It is a tool used to measure how much migraines affect a person's daily life and productivity. Scores on the MIDAS are highly correlated with physician judgments about the severity of illness and need for treatment. The score of this instrument is as follows: little or no disability, 5 to 10; moderate disability, 1 to 20; and severe disability, more than 20.
Time frame: Baseline and three months from last acupuncture stimulation
Biomarkers of brain injury and inflammatory response
We will take blood samples for interleukin - 6, 8 and 10 (Il6, IL8, IL10), leptin, Nerve growth factor (NGF), S100 calcium-binding protein A8 (S100A8), Brain-derived neurotrophic factor (BDNF) and CGRP
Time frame: Baseline, day of last acupuncture stimulation and three months from last acupuncture stimulation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.